129 related articles for article (PubMed ID: 1662521)
1. Lack of correlation between hepatitis B virus infection and the increasing incidence of primary liver cancer in Sweden.
Kaczynski J; Hansson G; Norkrans G; Wallerstedt S
Acta Oncol; 1991; 30(7):811-3. PubMed ID: 1662521
[TBL] [Abstract][Full Text] [Related]
2. The role of hepatitis B virus in the etiology of hepatocellular carcinoma in Australia.
Dalgleish AG; Woods RL; Levi JA; Raghavan D; McCaughan GW; Tattersall MH
Aust N Z J Med; 1983 Dec; 13(6):605-7. PubMed ID: 6326728
[TBL] [Abstract][Full Text] [Related]
3. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?
Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK
Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777
[TBL] [Abstract][Full Text] [Related]
4. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis B virus antigens in liver resections from patients with hepatocellular carcinoma].
Decker T; Ruhnke M
Zentralbl Allg Pathol; 1988; 134(2):197-205. PubMed ID: 2844035
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis DNA viruses and their correlation to hepatocellular cancer].
Roggendorf M
Internist (Berl); 1985 Oct; 26(10):621-7. PubMed ID: 3000972
[No Abstract] [Full Text] [Related]
7. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response.
Hsu HC; Wu TT; Wu MZ; Wu CY; Chiou TJ; Sheu JC; Lee CS; Chen DS
Cancer; 1988 Sep; 62(5):915-21. PubMed ID: 2842026
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
9. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
[TBL] [Abstract][Full Text] [Related]
10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
12. A prospective cohort study of hepatitis B surface antigen carriers in a working population.
Iijma T; Saitoh N; Nobutomo K; Nambu M; Sakuma K
Gan; 1984 Jul; 75(7):571-3. PubMed ID: 6088348
[TBL] [Abstract][Full Text] [Related]
13. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
Zhou XD; DeTolla L; Custer RP; London WT
Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
[TBL] [Abstract][Full Text] [Related]
14. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
15. [Double immunohistochemical staining of HBsAg and HBcAg in hepatocellular carcinoma and its surrounding tissue].
Jiang Z
Zhonghua Bing Li Xue Za Zhi; 1988 Dec; 17(4):251-3. PubMed ID: 2855470
[No Abstract] [Full Text] [Related]
16. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
[TBL] [Abstract][Full Text] [Related]
17. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Katayama K; Fusamoto H; Kamada T
Dig Dis Sci; 1992 Jan; 37(1):65-72. PubMed ID: 1309450
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in cirrhotic patients: role of hepatitis B virus.
Leandro G; Colloredo G; Cozzolongo R; Elba S
Ital J Gastroenterol; 1990 Apr; 22(2):66-9. PubMed ID: 1966704
[TBL] [Abstract][Full Text] [Related]
20. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Larouzé B; Blumberg BS; London WT; Lustbader ED; Sankalé M; Payet M
J Natl Cancer Inst; 1977 Jun; 58(6):1557-61. PubMed ID: 68119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
